Preconditioning or Postconditioning with 8-Br-cAMP-AM Protects the Heart Against Regional Ischemia and Reperfusion: A Role for Mitochondrial Permeability Transition

Overview

Journal Cells

Publisher MDPI

Specialties Biochemistry
Biophysics
Cell Biology
Molecular Biology

Date 2021 Jun 2

PMID 34067674

Citations 4

Authors

Igor Khaliulin

Raimondo Ascione

Leonid N Maslov

Haitham Amal

M Saadeh Suleiman

Affiliations

Soon will be listed here.

Abstract

The cAMP analogue 8-Br-cAMP-AM (8-Br) confers marked protection against global ischaemia/reperfusion of isolated perfused heart. We tested the hypothesis that 8-Br is also protective under clinically relevant conditions (regional ischaemia) when applied either before ischemia or at the beginning of reperfusion, and this effect is associated with the mitochondrial permeability transition pore (MPTP). 8-Br (10 μM) was administered to Langendorff-perfused rat hearts for 5 min either before or at the end of 30 min regional ischaemia. Ca-induced mitochondria swelling (a measure of MPTP opening) and binding of hexokinase II (HKII) to mitochondria were assessed following the drug treatment at preischaemia. Haemodynamic function and ventricular arrhythmias were monitored during ischaemia and 2 h reperfusion. Infarct size was evaluated at the end of reperfusion. 8-Br administered before ischaemia attenuated ventricular arrhythmias, improved haemodynamic function, and reduced infarct size during ischaemia/reperfusion. Application of 8-Br at the end of ischaemia protected the heart during reperfusion. 8-Br promoted binding of HKII to the mitochondria and reduced Ca-induced mitochondria swelling. Thus, 8-Br protects the heart when administered before regional ischaemia or at the beginning of reperfusion. This effect is associated with inhibition of MPTP via binding of HKII to mitochondria, which may underlie the protective mechanism.

Citing Articles

Mitochondrial Kinase Signaling for Cardioprotection.

Boengler K, Eickelmann C, Kleinbongard P Int J Mol Sci. 2024; 25(8).

PMID: 38674076 PMC: 11049936. DOI: 10.3390/ijms25084491.

Modification of Ischemia/Reperfusion-Induced Alterations in Subcellular Organelles by Ischemic Preconditioning.

Tappia P, Shah A, Ramjiawan B, Dhalla N Int J Mol Sci. 2022; 23(7).

PMID: 35408783 PMC: 8998910. DOI: 10.3390/ijms23073425.

Cardioprotection of Immature Heart by Simultaneous Activation of PKA and Epac: A Role for the Mitochondrial Permeability Transition Pore.

Lewis M, Khaliulin I, Hall K, Suleiman M Int J Mol Sci. 2022; 23(3).

PMID: 35163640 PMC: 8836102. DOI: 10.3390/ijms23031720.

Mitochondrial Quality Control in Cardiac-Conditioning Strategies against Ischemia-Reperfusion Injury.

Garcia-Nino W, Zazueta C, Buelna-Chontal M, Silva-Palacios A Life (Basel). 2021; 11(11).

PMID: 34832998 PMC: 8620839. DOI: 10.3390/life11111123.

References

Di Lisa F, Bernardi P . Mitochondria and ischemia-reperfusion injury of the heart: fixing a hole. Cardiovasc Res. 2006; 70(2):191-9. DOI: 10.1016/j.cardiores.2006.01.016. View

Gadeberg H, Bond R, Kong C, Chanoit G, Ascione R, Cannell M . Heterogeneity of T-Tubules in Pig Hearts. PLoS One. 2016; 11(6):e0156862. PMC: 4900646. DOI: 10.1371/journal.pone.0156862. View

Smith A, Owen J, Borgman K, Fish F, Kannankeril P . Relation of milrinone after surgery for congenital heart disease to significant postoperative tachyarrhythmias. Am J Cardiol. 2011; 108(11):1620-4. PMC: 3941037. DOI: 10.1016/j.amjcard.2011.07.023. View

Wu Z, Iivainen T, Pehkonen E, Laurikka J, Tarkka M . Antiarrhythmic effect of ischemic preconditioning in recent unstable angina patients undergoing coronary artery bypass grafting. World J Surg. 2003; 28(1):74-9. DOI: 10.1007/s00268-003-6861-7. View

Argaud L, Gateau-Roesch O, Raisky O, Loufouat J, Robert D, Ovize M . Postconditioning inhibits mitochondrial permeability transition. Circulation. 2005; 111(2):194-7. DOI: 10.1161/01.CIR.0000151290.04952.3B. View

Lochner A, Genade S, Tromp E, Podzuweit T, Moolman J . Ischemic preconditioning and the beta-adrenergic signal transduction pathway. Circulation. 1999; 100(9):958-66. DOI: 10.1161/01.cir.100.9.958. View

El-Armouche A, Zolk O, Rau T, Eschenhagen T . Inhibitory G-proteins and their role in desensitization of the adenylyl cyclase pathway in heart failure. Cardiovasc Res. 2003; 60(3):478-87. DOI: 10.1016/j.cardiores.2003.09.014. View

Walker M, Curtis M, Hearse D, CAMPBELL R, Janse M, Yellon D . The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res. 1988; 22(7):447-55. DOI: 10.1093/cvr/22.7.447. View

Hausenloy D, Duchen M, Yellon D . Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury. Cardiovasc Res. 2003; 60(3):617-25. DOI: 10.1016/j.cardiores.2003.09.025. View

10.

da-Silva W, Gomez-Puyou A, Tuena de Gomez-Puyou M, Moreno-Sanchez R, De Felice F, de Meis L . Mitochondrial bound hexokinase activity as a preventive antioxidant defense: steady-state ADP formation as a regulatory mechanism of membrane potential and reactive oxygen species generation in mitochondria. J Biol Chem. 2004; 279(38):39846-55. DOI: 10.1074/jbc.M403835200. View

11.

Bos J . Epac: a new cAMP target and new avenues in cAMP research. Nat Rev Mol Cell Biol. 2003; 4(9):733-8. DOI: 10.1038/nrm1197. View

12.

Pereira G, Lee L, Rawlings N, Ouwendijk J, Parker J, Andrienko T . Hexokinase II dissociation alone cannot account for changes in heart mitochondrial function, morphology and sensitivity to permeability transition pore opening following ischemia. PLoS One. 2020; 15(6):e0234653. PMC: 7313731. DOI: 10.1371/journal.pone.0234653. View

13.

Halestrap A, Clarke S, Javadov S . Mitochondrial permeability transition pore opening during myocardial reperfusion--a target for cardioprotection. Cardiovasc Res. 2004; 61(3):372-85. DOI: 10.1016/S0008-6363(03)00533-9. View

14.

Di Lisa F, Menabo R, Canton M, Barile M, Bernardi P . Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J Biol Chem. 2000; 276(4):2571-5. DOI: 10.1074/jbc.M006825200. View

15.

Baines C . The mitochondrial permeability transition pore and ischemia-reperfusion injury. Basic Res Cardiol. 2009; 104(2):181-8. PMC: 2671061. DOI: 10.1007/s00395-009-0004-8. View

16.

Pastorino J, Shulga N, Hoek J . Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. J Biol Chem. 2001; 277(9):7610-8. DOI: 10.1074/jbc.M109950200. View

17.

Marais E, Genade S, Lochner A . CREB activation and ischaemic preconditioning. Cardiovasc Drugs Ther. 2008; 22(1):3-17. DOI: 10.1007/s10557-007-6078-3. View

18.

Ito H, Okamura A, Iwakura K, Masuyama T, Hori M, Takiuchi S . Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation. 1996; 93(11):1993-9. DOI: 10.1161/01.cir.93.11.1993. View

19.

Clarke S, Khaliulin I, Das M, Parker J, Heesom K, Halestrap A . Inhibition of mitochondrial permeability transition pore opening by ischemic preconditioning is probably mediated by reduction of oxidative stress rather than mitochondrial protein phosphorylation. Circ Res. 2008; 102(9):1082-90. PMC: 2629616. DOI: 10.1161/CIRCRESAHA.107.167072. View

20.

Khaliulin I, Clarke S, Lin H, Parker J, Suleiman M, Halestrap A . Temperature preconditioning of isolated rat hearts--a potent cardioprotective mechanism involving a reduction in oxidative stress and inhibition of the mitochondrial permeability transition pore. J Physiol. 2007; 581(Pt 3):1147-61. PMC: 1976396. DOI: 10.1113/jphysiol.2007.130369. View